Evaluation of a semi-automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers

about

Evaluation of a semi-automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers

Item

http://www.wikidata.org/entity/Q57824128

description

scientific article published on 12 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Evaluation of a semi-automated ...... timer, by two European Centers

@en

Evaluation of a semi-automated ...... timer, by two European Centers

@nl

type

Item

label

Evaluation of a semi-automated ...... timer, by two European Centers

@en

Evaluation of a semi-automated ...... timer, by two European Centers

@nl

prefLabel

Evaluation of a semi-automated ...... timer, by two European Centers

@en

Evaluation of a semi-automated ...... timer, by two European Centers

@nl

P1476

Evaluation of a semi-automated ...... timer, by two European Centers

@en

P2093

Anne Goodeve

http://www.w3.org/2001/XMLSchema#string

Karen J Goodfellow

http://www.w3.org/2001/XMLSchema#string

Michael Makris

http://www.w3.org/2001/XMLSchema#string

Philipp Westhofen

http://www.w3.org/2001/XMLSchema#string

Stephen Kitchen

http://www.w3.org/2001/XMLSchema#string

P2860

Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization.

The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant v

Investigation of a large kindred with type IIB von Willebrand's disease, dominant inheritance and age-dependent thrombocytopenia.

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.

The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.

Acquired von Willebrand syndrome: features and management.

Haemate P/Humate-P for the treatment of von Willebrand disease: considerations for use and clinical experience.

Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH.

Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imaging.

Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique.

P304

790-799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/RTH2.12141

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

H Seidel

A Bowyer

F Stufano

P577

2018-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30349898

http://www.w3.org/2001/XMLSchema#string

P921

automation

P932

6178608

http://www.w3.org/2001/XMLSchema#string